Jonathan Biller - Chief Financial Officer at AGIOS PHARMACEUTICALS, INC.

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
AGIO on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Jonathan Biller since 19 Aug 2025

Reported holdings for Jonathan Biller in AGIOS PHARMACEUTICALS, INC.

Form 4 holding Chief Financial Officer

AGIOS PHARMACEUTICALS, INC.

Security class
Restricted stock units
Shares / value
11,500
Estimated value
$285,085
Report date
01 Mar 2022
Price
$24.79
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding Chief Financial Officer

AGIOS PHARMACEUTICALS, INC.

Security class
Stock options (right to buy)
Shares / value
41,000
Estimated value
Report date
01 Mar 2022
Price
Ownership
Direct
Underlying class
Common stock
Underlying amount

Transaction history for Jonathan Biller in AGIOS PHARMACEUTICALS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .